TCTMD

Tendyne Announces Successful First Human Implants of the Tendyne Transcatheter Mitral Valve Implant (TMVI)

ROSEVILLE, Minn., Tendyne Holdings, Inc. ("Tendyne"), a privately held clinical stage medical device company, announced today that the Tendyne Transcatheter Mitral Valve system has been successfully ...
Becker's Hospital Review

Saint Alphonsus first in Idaho to perform Tendyne mitral valve replacement

Boise, Idaho-based Saint Alphonsus Regional Medical Center became the first in the state to perform a Tendyne mitral valve replacement, the Daily Fly reported Dec. 7. The device is inserted through a ...
Nasdaq

Abbott's Tendyne™ Device Receives World's First CE Mark for Transcatheter Mitral Valve Implantation

ABBOTT PARK, Ill., Jan. 30, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that its Tendyne™ Transcatheter Mitral Valve Implantation (TMVI) system received CE Mark and is now approved for use ...
Medscape

Tendyne Device Shows Promise for Mitral Annular Calcification

Transcatheter implantation of the Tendyne mitral valve replacement device for treatment of mitral regurgitation in patients at prohibitive surgical risk because of severe mitral annular calcification ...
Medscape

Tendyne Transcatheter Mitral Valve Shows Sustained Benefits at 2 Years

Two-year outcomes following transcatheter mitral valve replacement with the Tendyne prosthesis showed durable control of mitral regurgitation, sustained improvement in quality of life and functional ...
Seeking Alpha

Abbott Receives FDA Approval for Tendyne™, First-of-Its-Kind Device to Replace the Mitral Valve Without Open-Heart Surgery

The Tendyne system replaces mitral valves that are not functioning properly due to a buildup of calcium in the base of the valves, known as severe mitral annular calcification (MAC) Tendyne offers a ...